Form 4 for CGNX COGNEX CORP
Accepted 2022-12-15 00:00:00 ET · period of report 2022-12-13 · accession 0001401616-22-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-15 | 2022-12-13 | CGNX | KRANTZ THEODOR | Dir | S - Sale+OE | $51.60 | -76.8K | 36.1K | -68% | -$3.96M |
| DM | 2022-12-15 | 2022-12-13 | CGNX | KRANTZ THEODOR | Dir | M - OptEx | $30.20 | +76.8K | 51.7K | New | +$2.32M |
| DM | 2022-12-15 | 2022-12-13 | CGNX | KRANTZ THEODOR | Dir | M - OptEx | $0.00 | -76.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-13 | S | D | 26,000 | $51.40 | 36,108 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-13 | M | A | 9,200 | $50.94 | 45,308 | D | — | — | |
| 3 | Common | Common Stock | 2022-12-13 | M | A | 26,000 | $19.66 | 62,108 | D | — | — | |
| 4 | Common | Common Stock | 2022-12-13 | S | D | 9,200 | $52.00 | 36,108 | D | — | — | |
| 5 | Common | Common Stock | 2022-12-13 | M | A | 26,000 | $20.63 | 62,108 | D | — | — | |
| 6 | Common | Common Stock | 2022-12-13 | S | D | 26,000 | $51.40 | 36,108 | D | — | — | |
| 7 | Common | Common Stock | 2022-12-13 | M | A | 15,600 | $51.49 | 51,708 | D | — | — | |
| 8 | Common | Common Stock | 2022-12-13 | S | D | 15,600 | $52.01 | 36,108 | D | — | — | |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-12-13 | M | D | 26,000 | $0.00 | 0 | D | $20.63 · 2016-02-17 to 2025-02-17 | 26,000 Common Stock | (F4) The options vest in four equal annual installments on the first, second, third, and fourth anniversaries of the grant date (February 17, 2015). |
| 10 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-12-13 | M | D | 9,200 | $0.00 | 13,800 | D | $50.94 · 2021-02-18 to 2030-02-18 | 9,200 Common Stock | (F5) The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2020). |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-12-13 | M | D | 15,600 | $0.00 | 10,400 | D | $51.49 · 2020-02-19 to 2029-02-19 | 15,600 Common Stock | (F6) The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019). |
| 12 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-12-13 | M | D | 26,000 | $0.00 | 0 | D | $19.66 · 2015-02-18 to 2024-02-18 | 26,000 Common Stock | (F3) The options vest in four equal annual installments on the first, second, third, and fourth anniversaries of the grant date (February 18, 2014). |